info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Encephalomyelitis Companies

Encephalomyelitis companies specialize in addressing encephalomyelitis, an inflammation of the brain and spinal cord. These companies contribute to neurology and immunology by providing diagnostic tools, medications, and therapies for managing and treating different forms of encephalomyelitis, including autoimmune and infectious etiologies.

Encephalomyelitis Key Companies

 

Latest Encephalomyelitis Companies Update


Jan 2024Valneva SE Received positive Phase IIa clinical trial results for their investigational vaccine, Ixi-CMV, against cytomegalovirus (CMV) encephalitis, a common cause of encephalitis in immunocompromised individuals.Partnered with leading research institutions to develop new vaccines and diagnostic tools for diverse forms of encephalitis, including Japanese encephalitis and West Nile virus encephalitis.


Genentech (Roche) Received FDA approval for Actemra (tocilizumab) for treating pediatric patients with multisystem inflammatory syndrome in children (MIS-C), a condition sometimes associated with post-infectious encephalitis.Conducted research on combining Actemra with other immunomodulatory therapies for synergistic effects in managing severe cases of encephalitis with significant inflammatory components.


GlaxoSmithKline (GSK) Launched a global awareness campaign highlighting the importance of timely diagnosis and treatment of encephalitis, addressing the often-unfamiliar nature of this condition.Collaborated with healthcare providers to improve clinical guidelines and treatment protocols for different types of encephalitis, emphasizing personalized care and optimizing patient outcomes.


List of Encephalomyelitis Key Companies in the Market



  • Bristol-Myers Squibb Company (U.S.)

  • Sanofi (France)

  • GlaxoSmithKline Plc. (U.K)

  • Spectrum Pharmaceuticals Inc. (U.S.)

  • Amgen, Inc. (U.S.)

  • Merck & Co., Inc. (U.S.)

  • Bayer AG (Germany)

  • Novartis AG (Switzerland)

  • F. Hoffmann-La Roche Ltd. (Switzerland)

  • Eli Lilly and Company (U.S.)

  • AstraZeneca Plc. (U.K)

  • Janssen Biotech, Inc. (U.S.)

  • AbbVie Inc. (U.S.)

  • Takeda Pharmaceuticals (Japan)

  • Immunomedics (U.S.)

  • Pfizer, Inc. (U.S.)

  • Oncomed Pharmaceuticals (U.S.)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.